ClinicalTrials.Veeva

Menu

Active Monitoring And Determinants of Incidence Infection of COVDI-19

F

Fundación Teófilo Hernando, Spain

Status

Unknown

Conditions

Coronavirus Infection

Study type

Observational

Funder types

Other

Identifiers

NCT04326400
AMADIICH

Details and patient eligibility

About

  1. Objectives To apply e-health methods to perform active monitoring and assess determinants of incident Infection of COVID-19 in a hospital population.

  2. Study design Prospective, Single-centre, observational clinical study. 9. Disease or disorder under study Healthy people in risk of COVID-19 infection. 10. Main variable. Symptoms related to infection caused by SARS-Cov2. 11. Study population and total number of patients Men and women in general god health status aged between 18 and 80 years that currently are employees of Hospital de La Princesa .

  3. Duration of treatment Each subject will be monitored, since its recruitment, for a period of 12 weeks.

  4. Timetable and expected date of completion The overall duration of the study is estimated at about 6 months, from patient recruitment to the last data recorded by last subject. The aim is to carry out this study from March 2020 onwards.

Enrollment

1,000 estimated patients

Sex

All

Ages

18 to 80 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  1. Male or female subject age ≥ 18 years.

  2. The subject has no symptoms in last week of COVID-19 infection such as:

    • Body temperature ≤ 37, 1 ºC.
    • Normal lung and breath functions.
  3. The subject belongs to the Hospital de La Princesa workforce.

Exclusion criteria

  1. People with any symptom suspicious of COVID-19 infection.

Trial design

1,000 participants in 1 patient group

Hospital de la Princesa employees

Trial contacts and locations

1

Loading...

Central trial contact

Marcos Maroto; Artuto García

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems